The latest price target for Inspire Medical Systems (NYSE:INSP) was reported by Truist Securities on February 11, 2025. The analyst firm set a price target for $235.00 expecting INSP to rise to within 12 months (a possible 32.53% upside). 28 analyst firms have reported ratings in the last year.

The latest analyst rating for Inspire Medical Systems (NYSE:INSP) was provided by Truist Securities, and Inspire Medical Systems maintained their buy rating.

The last upgrade for Inspire Medical Systems Inc happened on November 20, 2024 when B of A Securities raised their price target to $255. B of A Securities previously had a neutral for Inspire Medical Systems Inc.

The last downgrade for Inspire Medical Systems Inc happened on January 2, 2024 when Stifel changed their price target from N/A to $210 for Inspire Medical Systems Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Inspire Medical Systems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Inspire Medical Systems was filed on February 11, 2025 so you should expect the next rating to be made available sometime around February 11, 2026.

While ratings are subjective and will change, the latest Inspire Medical Systems (INSP) rating was a maintained with a price target of $250.00 to $235.00. The current price Inspire Medical Systems (INSP) is trading at is $177.32, which is out of the analyst’s predicted range.